Value considerations in the treatment of head and neck cancer: radiation, chemotherapy, and supportive care

Shrujal S. Baxi, David J. Sher, David G. Pfister

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

The management of head and neck cancer has advanced in many areas, including but not limited to diagnostic imaging and response assessment, radiation delivery, surgical approaches, combined-modality therapy, as well as new drug discovery. These advances have become widely used, however, the associated improvements in outcomes of interest compared with other options may at times be modest in magnitude or supported by limited data. In addition, the price tag of these advancements is often high. There is a growing mandate to look at existing data to identify insights into how to improve the value of care and to better understand the comparative effectiveness of one intervention versus another with regard to tumor control, quality of life, and other important outcomes; such insights become particularly important when considerable disparities exist in related costs. We review selected issues in radiotherapy, chemotherapy and supportive care applicable to the management of head and neck cancer and relevant to ascertaining the value of care.

Fingerprint

Head and Neck Neoplasms
Radiation
Drug Therapy
Combined Modality Therapy
Diagnostic Imaging
Drug Discovery
Radiotherapy
Quality of Life
Costs and Cost Analysis
Therapeutics
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{9617c1f5b3224e65a2f2039bb64195e9,
title = "Value considerations in the treatment of head and neck cancer: radiation, chemotherapy, and supportive care",
abstract = "The management of head and neck cancer has advanced in many areas, including but not limited to diagnostic imaging and response assessment, radiation delivery, surgical approaches, combined-modality therapy, as well as new drug discovery. These advances have become widely used, however, the associated improvements in outcomes of interest compared with other options may at times be modest in magnitude or supported by limited data. In addition, the price tag of these advancements is often high. There is a growing mandate to look at existing data to identify insights into how to improve the value of care and to better understand the comparative effectiveness of one intervention versus another with regard to tumor control, quality of life, and other important outcomes; such insights become particularly important when considerable disparities exist in related costs. We review selected issues in radiotherapy, chemotherapy and supportive care applicable to the management of head and neck cancer and relevant to ascertaining the value of care.",
author = "Baxi, {Shrujal S.} and Sher, {David J.} and Pfister, {David G.}",
year = "2014",
month = "1",
day = "1",
doi = "10.14694/EdBook_AM.2014.34.e296",
language = "English (US)",
pages = "e296--e303",
journal = "American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting",
issn = "1548-8756",
publisher = "American Society of Clinical Oncology",

}

TY - JOUR

T1 - Value considerations in the treatment of head and neck cancer

T2 - radiation, chemotherapy, and supportive care

AU - Baxi, Shrujal S.

AU - Sher, David J.

AU - Pfister, David G.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - The management of head and neck cancer has advanced in many areas, including but not limited to diagnostic imaging and response assessment, radiation delivery, surgical approaches, combined-modality therapy, as well as new drug discovery. These advances have become widely used, however, the associated improvements in outcomes of interest compared with other options may at times be modest in magnitude or supported by limited data. In addition, the price tag of these advancements is often high. There is a growing mandate to look at existing data to identify insights into how to improve the value of care and to better understand the comparative effectiveness of one intervention versus another with regard to tumor control, quality of life, and other important outcomes; such insights become particularly important when considerable disparities exist in related costs. We review selected issues in radiotherapy, chemotherapy and supportive care applicable to the management of head and neck cancer and relevant to ascertaining the value of care.

AB - The management of head and neck cancer has advanced in many areas, including but not limited to diagnostic imaging and response assessment, radiation delivery, surgical approaches, combined-modality therapy, as well as new drug discovery. These advances have become widely used, however, the associated improvements in outcomes of interest compared with other options may at times be modest in magnitude or supported by limited data. In addition, the price tag of these advancements is often high. There is a growing mandate to look at existing data to identify insights into how to improve the value of care and to better understand the comparative effectiveness of one intervention versus another with regard to tumor control, quality of life, and other important outcomes; such insights become particularly important when considerable disparities exist in related costs. We review selected issues in radiotherapy, chemotherapy and supportive care applicable to the management of head and neck cancer and relevant to ascertaining the value of care.

UR - http://www.scopus.com/inward/record.url?scp=84938130062&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938130062&partnerID=8YFLogxK

U2 - 10.14694/EdBook_AM.2014.34.e296

DO - 10.14694/EdBook_AM.2014.34.e296

M3 - Review article

C2 - 24857116

AN - SCOPUS:84938130062

SP - e296-e303

JO - American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting

JF - American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting

SN - 1548-8756

ER -